ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 268

LARS Study: Latin American Rheumatologist Survey

Genessis Maldonado1, Maria Intriago 1, Enrique Soriano 2, Letty Moreno 3 and Carlos Rios 1, 1Universidad Espiritu Santo, Guayaquil, Ecuador, 2Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina., Buenos Aires, Buenos Aires, Argentina, 3Centro de Reumatología y Rehabilitación, Guayaquil, Ecuador

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: socio-economic inequities and socioeconomic factors, socioeconomic status

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Health Services Research Poster I – ACR/ARP

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: :Currently, Latin America does not have detailed information of rheumatologists in the region based on: education, working conditions, productivity, distribution of time between work activities and job satisfaction.

The purpose of this survey was to provide more information on the rheumatology community in Latin America.

Methods: :
A digital survey was created using the Google Forms platform, it was approved and endorsed by the scientific committee of PANLAR and later sent to the different rheumatology associations of the region. The data was analyzed in the statistical program SPSS v.23.

Results: :600 surveys of rheumatologists from 23 countries were received. The majority were females (53%). The mean age was 46.8 ± 11.7 [25-78] years, with a majority of mixed race 58%. 63.2% are married, 22.5% are single, 7.8% are divorced, 5.2% in free union and 1.3% are widowed. The mean number of children was 1 [0-7]. Birthplaces included Argentina (25.8%), Brazil (15.8%). The setting of the professional practice after obtaining the title of specialists was: public hospital (36.7%), private (23.8%), private / teaching in a university hospital (12.5%), public / teaching in a university hospital (12.6%), and industry (0.2%). The main place of work was in public / government hospitals by 33.5% followed by private practice 28.8%, private hospital 20.8%, university hospital 15.5%, nonprofit organizations 1% and retired 0.3%. The average of weekly working hours was 37.8 ± 17.7. 87.5% of the sample practices adult rheumatology, 12.7% pediatric rheumatology, 1.5% immunology and 3.5% another specialty. 30.2% had an early arthritis care center at their workplace, 70% had an infusion unit, 56.2% had ultrasound, 48% had a densitometer, 48.7% had a resonator and 78.5% had X-rays. 28.7% have training in ultrasound and 9.5% are in training period, 74.8% have training in reading densitometry and 3% in training period, 52.7% have training in resonance reading and 12.2% in training period. The average satisfaction with practice as a rheumatologist was 5.3/7, career options 4.3/7, geographic location 4.7/7, income 3.5/7, job security 3.7/7, colleagues and co-workers 4.5/7. 33.5% had an annual compensation of < 19,000 US dollars. Only 57.2% have malpractice insurance and 87.5% have medical insurance. 38.2% present at least one clinical comorbidity.

Conclusion: The majority of rheumatologists in the region feel satisfied with their clinical practice. This survey shows a low level of income for the region, however, more data should be obtained. This is the first study of its kind in Latin America, being an initiative for similar projects.


Disclosure: G. Maldonado, None; M. Intriago, None; E. Soriano, Abbvie, 2, 5, 8, ABBVIE, 2, 5, 8, AbbVie, 2, 5, 8, Amber, 8, Amgen, 5, 8, AMGEN, 5, 8, BMS, 8, BRISTOL, 8, Bristol MS, 8, BRISTOL MYERS SQUIBB, 8, Bristol-Myers Squibb, 8, eli lilly, 5, 8, Genzyme, 8, GENZYME, 8, GLAXO, 2, Glaxo, 2, glaxosmithkline, 2, GlaxoSmithKline, 2, GSK, 2, Janssen, 8, Lilly, 5, 8, LILLY, 5, 8, Novartis, 2, 5, 8, NOVARTIS, 2, 5, 8, PFIZER, 5, 8, Pfizer, 5, 8, Pfizer Inc, 5, 8, Roche, 2, 8, ROCHE, 2, 8, Sandoz, 5, SANDOZ, 5, Sanofi, 5, SANOFI, 5, SANOPHY, 5, UCB, 8; L. Moreno, None; C. Rios, None.

To cite this abstract in AMA style:

Maldonado G, Intriago M, Soriano E, Moreno L, Rios C. LARS Study: Latin American Rheumatologist Survey [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/lars-study-latin-american-rheumatologist-survey/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lars-study-latin-american-rheumatologist-survey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology